Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	38.09	34.33	66.66	22.47	46.35	64.07
Short-Term Investments	132.57	61.9	171.3	147.56	92.01	22.68
Cash & Short-Term Investments	170.66	96.23	237.96	170.03	138.36	86.74
Cash Growth	-12.41%	-59.56%	39.95%	22.89%	59.50%	-43.04%
Accounts Receivable	11.78	2.38	3.47	1.01	0.03	0.01
Inventory	0.28	0.28	0.23	0.38	-	-
Other Current Assets	3.32	3	4.53	5.13	2.48	2.16
Total Current Assets	186.03	101.9	246.19	176.55	140.87	88.92
Net Property, Plant & Equipment	8.88	9.18	7.32	7.51	8.48	3.45
Goodwill	44.54	44.54	44.54	44.54	44.54	44.54
Other Long-Term Assets	29.37	29.37	0.37	0.83	0.41	-
Total Assets	268.82	184.99	298.42	229.43	194.3	136.91
Accounts Payable	3	3.08	14.8	14.39	10.4	9.15
Accrued Expenses	6.9	13.19	30.45	17.16	12.78	12.97
Current Portion of Long-Term Debt	-	4.6	-	-	-	-
Total Current Liabilities	9.9	20.87	45.25	31.55	23.17	22.12
Long-Term Debt	49.68	49.41	100.3	99.51	48.58	-
Long-Term Leases	-	-	-	-	5.42	1.19
Other Long-Term Liabilities	6.38	7.17	6.92	5.27	-	-
Total Long-Term Liabilities	56.07	56.58	107.22	104.77	54	1.19
Total Liabilities	65.96	77.45	152.47	136.32	77.18	23.31
Preferred Stock	0	-	-	-	-	-
Common Stock	0.43	0.37	0.36	0.25	0.19	0.15
Treasury Stock	-2.84	-5.19	-4.62	-2.89	-2.06	-7.52
Additional Paid-in Capital	2,224	2,130	2,117	1,863	1,709	1,609
Accumulated Other Comprehensive Income	-0.13	0.03	0.12	0.03	-0.43	-0.01
Retained Earnings	-2,019	-2,018	-1,967	-1,767	-1,590	-1,488
Shareholders' Equity	202.86	107.54	145.95	93.11	117.12	113.6
Total Liabilities & Equity	268.82	184.99	298.42	229.43	194.3	136.91
Total Debt	49.68	54	100.3	99.51	54	1.19
Net Cash (Debt)	120.97	42.23	137.66	70.52	84.35	85.55
Net Cash Growth	186.48%	-69.33%	95.21%	-16.40%	-1.40%	-39.16%
Net Cash Per Share	0.33	0.12	0.43	0.32	0.51	0.59
Book Value	202.86	107.54	145.95	93.11	117.12	113.6
Book Value Per Share	0.54	0.30	0.46	0.42	0.71	0.78
Tangible Book Value	158.31	63	101.41	48.57	72.58	69.05
Tangible Book Value Per Share	0.42	0.17	0.32	0.22	0.44	0.47

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q